Desq Long
Sign in

Company

Theravance Biopharma, Inc.

TBPH · CIK 0001583107

SEC FORM 4
$56,706.52

Theravance Biopharma, Inc. (TBPH)

Sale of 3,329 shares at $17.0341 per share.

Reporting Person Farnum Rhonda · Officer Title SVP, COMM & MEDICAL AFFAIRS · Transaction Code S

Traded Sep 15, 2026 · Disclosed Sep 17, 2026

Source: SEC Form 4 · 0001898490-26-000014 · filed 2026-09-17 · View filing →

SEC FORM 4
$56,690.15

Theravance Biopharma, Inc. (TBPH)

Sale of 3,328 shares at $17.0343 per share.

Reporting Person Farnum Rhonda · Officer Title SVP, COMM & MEDICAL AFFAIRS · Transaction Code S

Traded Sep 15, 2026 · Disclosed Sep 17, 2026

Source: SEC Form 4 · 0001898490-26-000014 · filed 2026-09-17 · View filing →

SEC FORM 4
$113,396.67

Theravance Biopharma, Inc. (TBPH)

Sale of 6,657 shares at $17.0342 per share.

Reporting Person Farnum Rhonda · Officer Title SVP, COMM & MEDICAL AFFAIRS · Transaction Code S

Traded Sep 15, 2026 · Disclosed Sep 17, 2026

Source: SEC Form 4 · 0001898490-26-000014 · filed 2026-09-17 · View filing →

SEC FORM 4
$339,576.30

Theravance Biopharma, Inc. (TBPH)

Disposition (code F) of 20,034 shares at $16.95 per share.

Reporting Person Winningham Rick E · Officer Title CHIEF EXECUTIVE OFFICER · Transaction Code F

Traded Aug 20, 2026 · Disclosed Aug 24, 2026

Source: SEC Form 4 · 0001302443-26-000012 · filed 2026-08-24 · View filing →

SEC FORM 4
$96,055.65

Theravance Biopharma, Inc. (TBPH)

Disposition (code F) of 5,667 shares at $16.95 per share.

Reporting Person Farnum Rhonda · Officer Title SVP, COMM & MEDICAL AFFAIRS · Transaction Code F

Traded Aug 20, 2026 · Disclosed Aug 24, 2026

Source: SEC Form 4 · 0001898490-26-000012 · filed 2026-08-24 · View filing →

SEC FORM 4
$137,498.40

Theravance Biopharma, Inc. (TBPH)

Disposition (code F) of 8,112 shares at $16.95 per share.

Reporting Person Sawaf Aziz · Officer Title SVP & CHIEF FINANCIAL OFFICER · Transaction Code F

Traded Aug 20, 2026 · Disclosed Aug 24, 2026

Source: SEC Form 4 · 0001961289-26-000008 · filed 2026-08-24 · View filing →

SEC FORM 4
$134,786.40

Theravance Biopharma, Inc. (TBPH)

Disposition (code F) of 7,952 shares at $16.95 per share.

Reporting Person Grimaud Brett A. · Officer Title SVP, GEN COUNSEL AND SECRETARY · Transaction Code F

Traded Aug 20, 2026 · Disclosed Aug 24, 2026

Source: SEC Form 4 · 0001966698-26-000008 · filed 2026-08-24 · View filing →

SEC FORM 4
$106,073.10

Theravance Biopharma, Inc. (TBPH)

Disposition (code F) of 6,258 shares at $16.95 per share.

Reporting Person Miller Aine · Officer Title SVP, DEV & HEAD OF IRE OFFICE · Transaction Code F

Traded Aug 20, 2026 · Disclosed Aug 24, 2026

Source: SEC Form 4 · 0002012524-26-000008 · filed 2026-08-24 · View filing →